|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 350.28 USD | -0.07% |
|
+1.67% | +7.03% |
| 06-15 | Mizuho Securities Lifts Price Target on Amgen to $303 From $295, Keeps Outperform Rating | MT |
| 06-15 | Global drugmakers invest billions to boost US presence | RE |
Company Valuation: Amgen Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 126,718 | 140,139 | 154,142 | 140,103 | 176,250 | 189,184 | - | - |
| Change | - | 10.59% | 9.99% | -9.11% | 25.8% | 7.34% | - | - |
| Enterprise Value (EV) 1 | 151,990 | 169,779 | 207,811 | 188,229 | 221,725 | 230,416 | 224,267 | 218,738 |
| Change | - | 11.7% | 22.4% | -9.42% | 17.8% | 3.92% | -2.67% | -2.47% |
| P/E Ratio | 21.9x | 21.7x | 23.1x | 34.5x | 23x | 22.8x | 20.7x | 19.8x |
| PBR | 18.7x | 38.3x | 24.7x | 23.8x | 20.4x | 17x | 13.5x | 10.8x |
| PEG | - | 1.2x | 7.36x | -0.9x | 0.3x | 2.82x | 2.09x | 4.13x |
| Capitalization / Revenue | 4.88x | 5.32x | 5.47x | 4.19x | 4.8x | 5.01x | 4.88x | 4.76x |
| EV / Revenue | 5.85x | 6.45x | 7.37x | 5.63x | 6.03x | 6.1x | 5.79x | 5.5x |
| EV / EBITDA | 9.61x | 10.5x | 11.9x | 9.13x | 10.4x | 10.6x | 10.4x | 10.4x |
| EV / EBIT | 12.2x | 13.3x | 15.5x | 12.5x | 13.7x | 14x | 13.2x | 12.5x |
| EV / FCF | 18.1x | 19.3x | 28.2x | 18.1x | 27.4x | 17.1x | 14.8x | 14.3x |
| FCF Yield | 5.51% | 5.17% | 3.54% | 5.52% | 3.65% | 5.83% | 6.74% | 7% |
| Dividend per Share 2 | 7.04 | 7.76 | 8.52 | 9 | - | 10.09 | 10.66 | 11.13 |
| Rate of return | 3.13% | 2.95% | 2.96% | 3.45% | - | 2.88% | 3.04% | 3.18% |
| EPS 2 | 10.28 | 12.11 | 12.49 | 7.56 | 14.23 | 15.38 | 16.91 | 17.72 |
| Distribution rate | 68.5% | 64.1% | 68.2% | 119% | - | 65.6% | 63% | 62.8% |
| Net sales 1 | 25,979 | 26,323 | 28,190 | 33,424 | 36,751 | 37,780 | 38,749 | 39,740 |
| EBITDA 1 | 15,822 | 16,178 | 17,470 | 20,620 | 21,370 | 21,638 | 21,587 | 21,007 |
| EBIT 1 | 12,424 | 12,761 | 13,399 | 15,028 | 16,203 | 16,507 | 17,026 | 17,494 |
| Net income 1 | 5,893 | 6,552 | 6,717 | 4,090 | 7,711 | 8,265 | 9,041 | 9,541 |
| Net Debt 1 | 25,272 | 29,640 | 53,669 | 48,126 | 45,475 | 41,232 | 35,083 | 29,554 |
| Reference price 2 | 224.97 | 262.64 | 288.02 | 260.64 | 327.31 | 350.53 | 350.53 | 350.53 |
| Nbr of stocks (in thousands) | 563,266 | 533,579 | 535,178 | 537,533 | 538,481 | 539,708 | - | - |
| Announcement Date | 2/7/22 A | 1/31/23 A | 2/6/24 A | 2/4/25 A | 2/3/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.79x | 6.1x | 10.65x | 2.88% | 189B | |
| 33.05x | 12.01x | 24.74x | 0.6% | 1,007B | |
| 25.19x | 5.81x | 15.79x | 2.26% | 567B | |
| 27.13x | 6.62x | 13.53x | 3.1% | 392B | |
| 17.5x | 4.32x | 10.61x | 3.07% | 328B | |
| 20.98x | 5.43x | 13.17x | 2.95% | 277B | |
| 22.23x | 4.65x | 13.18x | 1.88% | 275B | |
| 12.63x | 4.73x | 9.67x | 3.97% | 196B | |
| -44.54x | 5.38x | 29.66x | 2.61% | 154B | |
| 12.16x | 3.18x | 7.75x | 6.74% | 148B | |
| Average | 14.91x | 5.82x | 14.88x | 3.01% | 353.42B | |
| Weighted average by Cap. | 21.95x | 7.24x | 16.85x | 2.31% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- AMGN Stock
- Valuation Amgen Inc.
Select your edition
All financial news and data tailored to specific country editions
